INEGY 10 MG80 MG TABLETS

Država: Izrael

Jezik: angleščina

Source: Ministry of Health

Aktivna sestavina:

EZETIMIBE; SIMVASTATIN

Dostopno od:

MERCK SHARP & DOHME ISRAEL LTD

Koda artikla:

C10AA01

Farmacevtska oblika:

TABLETS

Sestava:

SIMVASTATIN 80 MG; EZETIMIBE 10 MG

Pot uporabe:

PER OS

Tip zastaranja:

Required

Izdeluje:

MERCK SHARP & DOHME B.V., THE NETHERLANDS

Terapevtska skupina:

SIMVASTATIN

Terapevtsko območje:

SIMVASTATIN

Terapevtske indikacije:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH. Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

Datum dovoljenje:

2012-04-30